Literature DB >> 35692467

Acute toxoplasmosis can increase serum dopamine level.

Mostafa Omidian1, Qasem Asgari1, Mohammad Saleh Bahreini1, Shokoufeh Moshki2, Bahareh Sedaghat1, Seyed Jafar Adnani Sadati2,3.   

Abstract

Toxoplasmosis is a globally parasitic zoonotic disease transmitted by Toxoplasma gondii protozoa. This infection in its chronic form can cause a change in its host's specific behavior and is also associated with developing neuropsychological symptoms in humans. Changes in neurotransmitters' levels, especially dopamine, have been identified as a behavior change factor in the infected host. This study aimed to evaluate serum dopamine levels in acute murine toxoplasmosis. In this study, 50 mice infected with Toxoplasma were studied in 5 separate groups, and ten healthy mice were considered as negative control. For five consecutive days after parasite injection, blood sampling and serum isolation were performed daily from one of the groups. Serum dopamine levels were measured by HPLC method. Statistical studies showed that serum dopamine on the first to the fourth day after parasite inoculation was the same as the negative control, but the fifth day began to increase. The present study results indicate that dopamine production in mice infected with Toxoplasma gondii increases from day five after infection. This result suggests that in acute toxoplasmosis, dopamine production is low, and the trend of chronic disease increases dopamine production. © Indian Society for Parasitology 2021.

Entities:  

Keywords:  BALB/c mice; Dopamine; HPLC; Toxoplasma gondii

Year:  2021        PMID: 35692467      PMCID: PMC9177907          DOI: 10.1007/s12639-021-01447-1

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  38 in total

1.  Contribution of dopamine neurotransmission in proconvulsant effect of Toxoplasma gondii infection in male mice.

Authors:  Jalal Babaie; Mohammad Sayyah; Pezhman Fard-Esfahani; Majid Golkar; Kourosh Gharagozli
Journal:  J Neurosci Res       Date:  2017-03-07       Impact factor: 4.164

2.  Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice.

Authors:  H H Stibbs
Journal:  Ann Trop Med Parasitol       Date:  1985-04

3.  Toxoplasmosis: Recent Advances in Understanding the Link Between Infection and Host Behavior.

Authors:  Stefanie K Johnson; Pieter T J Johnson
Journal:  Annu Rev Anim Biosci       Date:  2020-11-02       Impact factor: 8.923

4.  Direct evidence of Toxoplasma-induced changes in serum testosterone in mice.

Authors:  Sárka Kaňková; Petr Kodym; Jaroslav Flegr
Journal:  Exp Parasitol       Date:  2011-03-31       Impact factor: 2.011

Review 5.  Toxoplasma gondii-induced neuronal alterations.

Authors:  A Parlog; D Schlüter; I R Dunay
Journal:  Parasite Immunol       Date:  2015-03       Impact factor: 2.280

Review 6.  Toxoplasmosis as a cause for behaviour disorders--overview of evidence and mechanisms.

Authors:  Abebaw Fekadu; Teshome Shibre; Anthony J Cleare
Journal:  Folia Parasitol (Praha)       Date:  2010-06       Impact factor: 2.122

7.  Evaluation of the Tyrosine and Dopamine Serum Levels in Experimental Infected BALB/c Mice with Chronic Toxoplasmosis.

Authors:  Mehdi Mirzaeipour; Fattaneh Mikaeili; Qasem Asgari; Mohammad Nohtani; Sajad Rashidi; Mohammad Saleh Bahreini
Journal:  J Parasitol Res       Date:  2021-08-17

8.  Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis.

Authors:  Jaroslav Flegr
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

Review 9.  The immunoregulatory role of dopamine: an update.

Authors:  Chandrani Sarkar; Biswarup Basu; Debanjan Chakroborty; Partha Sarthi Dasgupta; Sujit Basu
Journal:  Brain Behav Immun       Date:  2009-11-05       Impact factor: 7.217

10.  The aromatic amino acid hydroxylase genes AAH1 and AAH2 in Toxoplasma gondii contribute to transmission in the cat.

Authors:  Zi T Wang; Shiv K Verma; Jitender P Dubey; L David Sibley
Journal:  PLoS Pathog       Date:  2017-03-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.